🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Therapeutic indication: Ocular hypotensive Use: Primary open-angle glaucoma...
Status
Completed
Location
Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Start Date
2019-05-02
Trial ID
NCT03966365
Treatments Being Tested
This study will examine the efficacy and safety of Xalacom comparing with t...
Status
Completed
Location
Nomura Eye Clinic
Start Date
2006-11-14
Trial ID
NCT00383019
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus res...
Status
Completed
Location
University of Utah
Start Date
2020-01-19
Trial ID
NCT04467931
Treatments Being Tested
To assess the pharmacokinetic Interaction between Dorzolamide and Brimonidi...
Status
Completed
Location
Clinical Trial Center, Seoul National University Hospital
Start Date
2016-12
Trial ID
NCT02967614
Treatments Being Tested
One in four Veterans is affected by diabetes and will develop a diabetic fo...
Status
Completed
Location
VA Northern California Health Care System, Mather, CA
Start Date
2018-07-24
Trial ID
NCT03282981
Treatments Being Tested
In participants with a diagnosis of open angle glaucoma (OAG) or ocular hyp...
Status
Completed
Location
Bausch & Lomb Inc.
Start Date
2013-01-31
Trial ID
NCT01749904
Treatments Being Tested
Timolol is a nonselective β-blocker commonly used in the treatment of glauc...
Status
Completed
Location
Hospices Civils de Lyon - Hôpital Femme Mère Enfant / Service de génétique Clinique
Start Date
2015-06
Trial ID
NCT02484716
Treatments Being Tested
To analyze Cosopt® in terms of its effects on ocular perfusion pressure and...
Status
Completed
Location
Indiana University School of Medicine, Department of Ophthalmology
Start Date
2010-06
Trial ID
NCT01145898
Treatments Being Tested
Study PhXA41 for its non-inferiority compared with timolol in lowering intr...
Status
Completed
Location
Pfizer Investigational Site
Start Date
1992-12
Trial ID
NCT00751049
The purpose of this study is to evaluate the additive intraocular pressure ...
Status
Terminated
Location
Contact Alcon for Locations (Europe, Asia, and Latin America)
Start Date
2016-06-24
Trial ID
NCT02730871